These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 31597207)
1. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial. Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207 [TBL] [Abstract][Full Text] [Related]
2. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT. Hajek P; Phillips-Waller A; Przulj D; Pesola F; Smith KM; Bisal N; Li J; Parrott S; Sasieni P; Dawkins L; Ross L; Goniewicz M; Wu Q; McRobbie HJ Health Technol Assess; 2019 Aug; 23(43):1-82. PubMed ID: 31434605 [TBL] [Abstract][Full Text] [Related]
3. Nicotine replacement treatment, e-cigarettes and an online behavioural intervention to reduce relapse in recent ex-smokers: a multinational four-arm RCT. McRobbie HJ; Phillips-Waller A; El Zerbi C; McNeill A; Hajek P; Pesola F; Balmford J; Ferguson SG; Li L; Lewis S; Courtney RJ; Gartner C; Bauld L; Borland R Health Technol Assess; 2020 Dec; 24(68):1-82. PubMed ID: 33270009 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study. Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S; Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154 [TBL] [Abstract][Full Text] [Related]
5. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis. Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial. Wu Q; Gilbert H; Nazareth I; Sutton S; Morris R; Petersen I; Galton S; Parrott S Addiction; 2018 Apr; 113(4):708-718. PubMed ID: 29105871 [TBL] [Abstract][Full Text] [Related]
7. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448 [TBL] [Abstract][Full Text] [Related]
8. Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy. Przulj D; Pesola F; Myers Smith K; McRobbie H; Coleman T; Lewis S; Griffith C; Walton R; Whitemore R; Clark M; Ussher M; Sinclair L; Seager E; Cooper S; Bauld L; Naughton F; Sasieni P; Manyonda I; Hajek P Health Technol Assess; 2023 Jul; 27(13):1-53. PubMed ID: 37840301 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of extended cessation treatment for older smokers. Barnett PG; Wong W; Jeffers A; Munoz R; Humfleet G; Hall S Addiction; 2014 Feb; 109(2):314-22. PubMed ID: 24329972 [TBL] [Abstract][Full Text] [Related]
11. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Cooper S; Lewis S; Thornton JG; Marlow N; Watts K; Britton J; Grainge MJ; Taggar J; Essex H; Parrott S; Dickinson A; Whitemore R; Coleman T; Health Technol Assess; 2014 Aug; 18(54):1-128. PubMed ID: 25158081 [TBL] [Abstract][Full Text] [Related]
12. Nicotine preloading for smoking cessation: the Preloading RCT. Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863 [TBL] [Abstract][Full Text] [Related]
13. Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model. Jones M; Smith M; Lewis S; Parrott S; Coleman T Addiction; 2022 Nov; 117(11):2907-2917. PubMed ID: 35661312 [TBL] [Abstract][Full Text] [Related]
14. E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial. Myers Smith K; Phillips-Waller A; Pesola F; McRobbie H; Przulj D; Orzol M; Hajek P Addiction; 2022 Jan; 117(1):224-233. PubMed ID: 34187081 [TBL] [Abstract][Full Text] [Related]
15. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT. Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622 [TBL] [Abstract][Full Text] [Related]
16. Expenditure on smoking and alternative nicotine delivery products: a population survey in England. Jackson SE; Shahab L; Kock L; West R; Brown J Addiction; 2019 Nov; 114(11):2026-2036. PubMed ID: 31243842 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events. Keeney E; Welton NJ; Stevenson M; Dalili MN; López-López JA; Caldwell DM; Phillippo DM; Munafò MR; Thomas KH Value Health; 2021 Jun; 24(6):780-788. PubMed ID: 34119075 [TBL] [Abstract][Full Text] [Related]
18. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909 [TBL] [Abstract][Full Text] [Related]
20. Economic Evaluation of Enhanced vs Standard Varenicline Treatment for Tobacco Cessation. Mundt MP; Stein JH; Fiore MC; Baker TB JAMA Netw Open; 2024 Apr; 7(4):e248727. PubMed ID: 38683609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]